MedPath

Quality Indicators of care in Pediatric Medulloblastoma

Not Applicable
Conditions
Health Condition 1: C716- Malignant neoplasm of cerebellum
Registration Number
CTRI/2022/11/047162
Lead Sponsor
Dr Rimpa Basu Achari PI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age < 21 years

Histologically proven medulloblastoma

Planned for curative treatment/ received curative treatment at TMC Kolkata

Exclusion Criteria

Patients treated for recurrent disease

Patients receiving palliative treatment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of treatment courses where all pre-defined quality indicators were adhered to. <br/ ><br>Timepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
1. Determine reasons for non-adherence to quality indicators <br/ ><br>2. Evaluate association between baseline patient factors and adherence to quality indicators <br/ ><br>3. Evaluate association between adherence to quality indicators with outcomes viz overall and progression free survival determined by the hazard ratioTimepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath